SCHEMBL15947709

SCHEMBL15947709

COC(=O)CCC(=O)Nc1ncc(C=O)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA3 P07451 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CA5B Q9Y2D0 1/20 0.47
MAPK10 P53779 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PKM P14618 1/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 2/20 0.42
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28405114 0.88 CA12 (0.50) CA12CA1CA2CA3CA4
SCHEMBL15947687 0.86 SMN1; SMN2 (0.42) MAPK10SMN1; SMN2KMT2ALMNA
SCHEMBL3493311 0.83 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1POLBHPGDMAPT
SCHEMBL20284274 0.81 SMN1; SMN2 (0.46) CA1CA2CA4CA9MAPK10
SCHEMBL10176144 0.79 SMN1; SMN2 (0.51) SMN1; SMN2PKMKMT2AHTTALDH1A1
SCHEMBL15940820 0.77 CA12 (0.46) CA12CA1CA2CA3CA4
SCHEMBL4100380 0.76 CSNK2A2 (0.46) KMT2AMAPTLMNA
SCHEMBL10227546 0.74 CSNK2A2 (0.41) MAPK10SMN1; SMN2HTTALDH1A1POLB
SCHEMBL10176139 0.74 ALDH1A1 (0.48) SMN1; SMN2PKMKMT2AHTTALDH1A1
SCHEMBL7019955 0.74 CSNK2A2 (0.47) SMN1; SMN2PKMKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10399950-B2 Substituted amino azoles as plant growth regulators SYNGENTA PARTCIPATIONS AG (CH) 2019-09-03 US disclosed
EP-2953946-B1 SUBSTITUTED AMINO AZOLES AS PLANT GROWTH REGULATORS SYNGENTA PARTICIPATIONS AG (CH) 2016-11-02 EP disclosed
US-20150376150-A1 SUBSTITUTED AMINO AZOLES AS PLANT GROWTH REGULATORS SYNGENTA LIMITED (GB) 2015-12-31 US disclosed
US-20150376150-A1 SUBSTITUTED AMINO AZOLES AS PLANT GROWTH REGULATORS SYNGENTA LIMITED (GB) 2015-12-31 US disclosed
WO-2014122066-A1 SUBSTITUTED AMINO AZOLES AS PLANT GROWTH REGULATORS SYNGENTA PARTICIPATIONS AG (CH) 2014-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10399950-B2 Substituted amino azoles as plant growth regulators NR5A1, CRY1, NR2E3 CA12 4344/4885CA1 3418/4885CA2 3147/4885
US-20150376150-A1 SUBSTITUTED AMINO AZOLES AS PLANT GROWTH REGULATORS NR5A1, CRY1, NR2E3 CA12 4344/4885CA1 3418/4885CA2 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.